OpGen (OPGN) Competitors $4.70 +0.01 (+0.21%) As of 12:10 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsSEC FilingsShort InterestTrendsBuy This Stock OPGN vs. DCGO, XGN, CORBF, EUDA, KDLY, QIPT, ATPC, BMGL, SERA, and PIIIShould you be buying OpGen stock or one of its competitors? The main competitors of OpGen include DocGo (DCGO), Exagen (XGN), Global Cord Blood (CORBF), EUDA Health (EUDA), Kindly MD (KDLY), Quipt Home Medical (QIPT), Agape ATP (ATPC), Basel Medical Group (BMGL), Sera Prognostics (SERA), and P3 Health Partners (PIII). These companies are all part of the "healthcare" industry. OpGen vs. DocGo Exagen Global Cord Blood EUDA Health Kindly MD Quipt Home Medical Agape ATP Basel Medical Group Sera Prognostics P3 Health Partners DocGo (NASDAQ:DCGO) and OpGen (NASDAQ:OPGN) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their media sentiment, valuation, community ranking, analyst recommendations, profitability, risk, earnings, dividends and institutional ownership. Do insiders and institutionals believe in DCGO or OPGN? 56.4% of DocGo shares are owned by institutional investors. Comparatively, 2.7% of OpGen shares are owned by institutional investors. 2.7% of DocGo shares are owned by company insiders. Comparatively, 43.8% of OpGen shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Which has more volatility and risk, DCGO or OPGN? DocGo has a beta of 0.94, meaning that its stock price is 6% less volatile than the S&P 500. Comparatively, OpGen has a beta of -1.68, meaning that its stock price is 268% less volatile than the S&P 500. Does the media favor DCGO or OPGN? In the previous week, DocGo had 2 more articles in the media than OpGen. MarketBeat recorded 2 mentions for DocGo and 0 mentions for OpGen. DocGo's average media sentiment score of 1.34 beat OpGen's score of 0.00 indicating that DocGo is being referred to more favorably in the media. Company Overall Sentiment DocGo Positive OpGen Neutral Do analysts recommend DCGO or OPGN? DocGo currently has a consensus target price of $3.56, indicating a potential upside of 132.68%. Given DocGo's stronger consensus rating and higher possible upside, equities analysts plainly believe DocGo is more favorable than OpGen.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score DocGo 0 Sell rating(s) 3 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.50OpGen 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Which has better earnings and valuation, DCGO or OPGN? DocGo has higher revenue and earnings than OpGen. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioDocGo$520.50M0.30$6.86M-$0.02-76.50OpGen$2.67M17.70-$32.67MN/AN/A Is DCGO or OPGN more profitable? DocGo has a net margin of 4.35% compared to OpGen's net margin of -1,140.36%. DocGo's return on equity of 8.90% beat OpGen's return on equity.Company Net Margins Return on Equity Return on Assets DocGo4.35% 8.90% 5.72% OpGen -1,140.36%N/A -287.58% Does the MarketBeat Community favor DCGO or OPGN? OpGen received 252 more outperform votes than DocGo when rated by MarketBeat users. However, 72.06% of users gave DocGo an outperform vote while only 51.81% of users gave OpGen an outperform vote. CompanyUnderperformOutperformDocGoOutperform Votes4972.06% Underperform Votes1927.94% OpGenOutperform Votes30151.81% Underperform Votes28048.19% SummaryDocGo beats OpGen on 13 of the 16 factors compared between the two stocks. Get OpGen News Delivered to You Automatically Sign up to receive the latest news and ratings for OPGN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart OPGN vs. The Competition Export to ExcelMetricOpGenMedical laboratories IndustryMedical SectorNASDAQ ExchangeMarket Cap$47.32M$3.21B$5.58B$8.64BDividend YieldN/A31.25%5.27%4.19%P/E RatioN/A15.0627.3720.17Price / Sales17.70172.00414.23164.07Price / CashN/A57.5638.2534.64Price / Book-0.414.837.164.72Net Income-$32.67M-$22.21M$3.23B$247.88M7 Day Performance3.30%3.70%6.50%4.30%1 Month Performance-4.28%7.90%15.27%10.63%1 Year Performance85.77%15.29%32.69%14.87% OpGen Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)OPGNOpGenN/A$4.70+0.2%N/A+77.7%$47.32M$2.67M0.00100Gap DownDCGODocGo3.4613 of 5 stars$1.60+4.6%$3.56+122.5%-48.6%$163.17M$520.50M5.712,920Positive NewsXGNExagen3.3956 of 5 stars$7.17-1.1%$7.50+4.6%+255.0%$154.43M$56.72M-7.63220CORBFGlobal Cord BloodN/A$1.19+18.5%N/A-3.7%$144.04M$196.12M0.001,200Gap UpEUDAEUDA Health0.2637 of 5 stars$3.36-2.3%N/A+34.4%$124.83M$4.01M0.002News CoverageKDLYKindly MD1.3692 of 5 stars$15.88-0.9%N/A+483.8%$95.63M$2.47M-20.62N/APositive NewsQIPTQuipt Home Medical2.7853 of 5 stars$2.16+8.0%$2.85+31.9%-32.5%$87.01M$240.85M-12.71800News CoverageOptions VolumeHigh Trading VolumeATPCAgape ATP0.3272 of 5 stars$1.50-2.0%N/A-71.2%$75.01M$1.29M-2.0540BMGLBasel Medical GroupN/A$4.41+12.2%N/AN/A$72.53M$10.05M0.0036Positive NewsGap DownSERASera Prognostics0.6309 of 5 stars$1.50-3.2%N/A-81.7%$58.39M$115,000.00-1.52120High Trading VolumePIIIP3 Health Partners1.3189 of 5 stars$6.56-0.9%$16.25+147.7%-76.6%$47.15M$1.49B-7.81500 Related Companies and Tools Related Companies DCGO Competitors XGN Competitors CORBF Competitors EUDA Competitors KDLY Competitors QIPT Competitors ATPC Competitors BMGL Competitors SERA Competitors PIII Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:OPGN) was last updated on 6/10/2025 by MarketBeat.com Staff From Our PartnersBanks aren’t ready for this altcoin—are you?While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredGet Ready for Elon Musk’s BIGGEST Comeback YetTesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredNew Rule Hits in July — The Smart Money Already MovedA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredBig Changes Coming to Social Security?According to legendary investor Louis Navellier... This new Trump move could soon not only save Social Secu...InvestorPlace | SponsoredSHOCKING: Musk's Pentagon Secret Mission...It's about a harrowing message discovered on December 16, 2024: "美国军方暗杀名单" It's the reason President Tru...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding OpGen, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share OpGen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
